BE898819A - Dispositif osmotique - Google Patents

Dispositif osmotique

Info

Publication number
BE898819A
BE898819A BE0/212326A BE212326A BE898819A BE 898819 A BE898819 A BE 898819A BE 0/212326 A BE0/212326 A BE 0/212326A BE 212326 A BE212326 A BE 212326A BE 898819 A BE898819 A BE 898819A
Authority
BE
Belgium
Prior art keywords
osmotic
composition
osmotic device
compartment
surrounds
Prior art date
Application number
BE0/212326A
Other languages
English (en)
Inventor
P S L Wong
B Barclay
J C Deters
F Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE898819(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of BE898819A publication Critical patent/BE898819A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

On prévoit un dispositif osmotique comprenant une paroi formée au moins en partie d'une matière semi-perméable qui entoure un compartiment, ce compartiment contenant une première composition osmotique comprenant un agent bénéfique, et une seconde composition osmotique différente de la première, une voie de passage dans la paroi reliant la première composition à l'extérieur du dispositif.
BE0/212326A 1983-05-11 1984-02-02 Dispositif osmotique BE898819A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (1)

Publication Number Publication Date
BE898819A true BE898819A (fr) 1984-05-30

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212326A BE898819A (fr) 1983-05-11 1984-02-02 Dispositif osmotique

Country Status (20)

Country Link
JP (1) JPS6041609A (fr)
AT (1) AT397180B (fr)
AU (1) AU566110B2 (fr)
BE (1) BE898819A (fr)
CA (1) CA1222950A (fr)
CH (1) CH669329A5 (fr)
DE (1) DE3417113A1 (fr)
DK (1) DK163910C (fr)
ES (1) ES532018A0 (fr)
FR (1) FR2545721B1 (fr)
GB (1) GB2140687B (fr)
IE (1) IE56515B1 (fr)
IL (1) IL71727A (fr)
IT (1) IT1178911B (fr)
MX (1) MX163518B (fr)
NL (1) NL192250C (fr)
NO (1) NO170834C (fr)
NZ (1) NZ206600A (fr)
SE (1) SE455918B (fr)
ZA (1) ZA842422B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (fr) * 1987-11-25 1992-05-20 American Cyanamid Company Système de délivrance retardée (contrôlée) de dihydropyridine antagonistes de calcium substitués
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
EP0550641B1 (fr) * 1990-09-28 1994-05-25 Pfizer Inc. Dispositif de distribution contenant un milieu hydrophobe
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ATE200221T1 (de) * 1993-02-23 2001-04-15 Wolfgang Dr Werner Die verwendung eines calciumpräparates in einem medikament zur behandlung von an hypocalcämie leidenden milchkühen
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AU2738302A (en) * 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (fr) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention et traitement de troubles thromboemboliques
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
CA2624310C (fr) 2005-10-04 2014-01-07 Bayer Healthcare Ag Forme polymorphique de 5 chloro n ({5s) 2 oxo 3 [4 (3 oxo 4 morpholinyl)phenyl] 1,3 oxazolidin 5 yl} methyl) 2 thiophenecarboxamidel)-2-thiophenecarboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US8956654B2 (en) * 2009-06-02 2015-02-17 Dow Global Technologies Llc Sustained release dosage form
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
IN2014DN09045A (fr) 2012-05-07 2015-05-22 Bayer Pharma AG
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
UY38308A (es) 2018-07-24 2020-02-28 Bayer Pharma AG Forma de dosificación farmacéutica administrable por vía oral con liberación modificada
CN112469398A (zh) 2018-07-24 2021-03-09 拜耳公司 可口服给药并具有缓释作用的药物剂型

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Also Published As

Publication number Publication date
ATA88084A (de) 1993-07-15
JPS6041609A (ja) 1985-03-05
CH669329A5 (fr) 1989-03-15
SE8402512L (sv) 1984-11-12
NO170834C (no) 1992-12-16
MX163518B (es) 1992-05-25
DE3417113A1 (de) 1984-11-15
ES8503503A1 (es) 1985-03-01
DK99784D0 (da) 1984-02-24
GB2140687B (en) 1987-03-18
NL192250B (nl) 1996-12-02
IE840010L (en) 1984-11-11
IT8467283A1 (it) 1985-09-23
SE455918B (sv) 1988-08-22
IL71727A0 (en) 1984-09-30
NL8401470A (nl) 1984-12-03
IT1178911B (it) 1987-09-16
GB2140687A (en) 1984-12-05
ES532018A0 (es) 1985-03-01
NO840248L (no) 1984-11-12
CA1222950A (fr) 1987-06-16
IL71727A (en) 1989-01-31
GB8334189D0 (en) 1984-02-01
AU566110B2 (en) 1987-10-08
NZ206600A (en) 1987-01-23
SE8402512D0 (sv) 1984-05-09
AU2251183A (en) 1984-11-15
IT8467283A0 (it) 1984-03-23
DK163910C (da) 1992-09-14
NO170834B (no) 1992-09-07
ZA842422B (en) 1984-11-28
DE3417113C2 (fr) 1989-02-02
JPH0575725B2 (fr) 1993-10-21
IE56515B1 (en) 1991-08-28
DK163910B (da) 1992-04-21
FR2545721A1 (fr) 1984-11-16
DK99784A (da) 1984-11-12
NL192250C (nl) 1997-04-03
AT397180B (de) 1994-02-25
FR2545721B1 (fr) 1987-11-06

Similar Documents

Publication Publication Date Title
BE898819A (fr) Dispositif osmotique
BE898820A (fr) Dispositif osmotique
FR2502642B1 (fr) Nouvel alliage au magnesium contenant de l'yttrium et du neodyme
ES509706A0 (es) "mejoras introducidas en el objeto de la patente principal n 504.302".
NL186746B (nl) Vloeistofafgeefinrichting en mengkamer.
MA22679A1 (fr) Dispositif pour delivrer de facon pulsee un liquide d'irrigation et systemes d'irrigation qui incorporent ce dispositif.
ES508017A0 (es) "perfeccionamientos en las valvulas de descarganretencion".
TR22099A (tr) Temizleme kokulu ve birlikte cahsan suerguelue oertue kapakh iki bicakh kartus
MA18873A1 (fr) Pompe de circulation pour la circulation d'un agent liquide et/ou gazeux
FR2717099B1 (fr) Agent d'extraction pour l'extraction sélective du strontium dans une solution aqueuse contenant celui-ci.
ES513337A0 (es) "aparato de mdida del caudal e un fluido".
NO870810D0 (no) Detersive systemer og lavtskummende vandige opploesninger av overflateaktive midler.
IT1233521B (it) Rivelatore di flusso d'ingresso di turbina e sistema di sigillatura.
KR850002818A (ko) 분리조(分離槽)
FR2656927B1 (fr) Dispositif d'immunotest du type plaquette a plonger, et trousse contenant ce dispositif.
BR9106664A (pt) Concentrado de agente tensoativo liquido,de livre fluxo e bombeavel
BE900745A (fr) Agencement d'electrodes pour le dessalement electrochimique et pour l'assechement de maconneries.
FR2541745B1 (fr) Dispositif de retenue d'une phase liquide entre une paroi et une piece tournante la traversant
IT8219444A0 (it) Sistema di giunzione di parti separate con possibilita' di unire e distaccare ripetutamente le parti stesse.
ES513855A0 (es) "perfeccionamientos en flujometros".
FR2549472B1 (fr) N-(2-methyl-2-pentenoyl)-4'-isopropyl-anilide, sa preparation et herbicide selectif le contenant
IT8419385A0 (it) Cavita' perfezionata che circonda una tubazione d'entrata o d'uscita del refrigerante di un reattore nucleare.
ES516183A0 (es) "un frigorifico que comprende un compartimiento de congelacion y un compartimiento de refrigueracion".
IT8224851A0 (it) Sistema di giunzione di parti separate con possibilita' di unire e distaccare ripetutamente le parti stesse.
ES515197A0 (es) Perfeccionamientos en una boca de distribucion de fluido con caudal independiente de la presion.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ALZA CORP.

Effective date: 20040202